April 10, 2025
11 a.m. EST

While mortality rates from cancer have declined rapidly in the last 30 years, cancer incidence rates among women are steadily increasing1. Breast, cervical, and ovarian are among the most common forms of cancer to affect women worldwide, and substantial unmet needs exist in their treatment. With recent diagnostic advances and the introduction of novel medicines, there is renewed interest and hope for progress in developing more effective gynecological and breast cancer treatments.

Success in bringing more effective treatments to market depends on designing studies that prioritize patient safety and experience. This involves tailoring recruitment strategies and trial environments to reflect the unique perspectives and needs of women.

In this webinar, we will discuss ways to enhance both patient recruitment and patient satisfaction, through a focus on safety monitoring, reducing trial burden, overcoming screening delays, providing proper training for sites, and using patient-reported outcomes as endpoints.

Attendees will gain insights into:

The landscape for women’s and gynecological oncology treatment

Strategies to enhance patient recruitment

Medical monitoring methods that help ensure patient safety and trial quality

Case studies involving breast, cervical, and ovarian cancer clinical trials

Registration Coming Soon

Speakers:

Ashley Herrick, PhD – Vice President, Oncology Program Strategy

Sandy Shah, MD – Vice President, Medical Affairs, Oncology/Hematology

Source:

1. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2025-cancer-facts-figures.html